Welcome to our dedicated page for Mettler-Toledo news (Ticker: MTD), a resource for investors and traders seeking the latest updates and insights on Mettler-Toledo stock.
Mettler-Toledo International supplies precision instruments and services used in laboratory, industrial and food retail applications. Its recurring news includes quarterly results, local-currency sales trends, adjusted earnings measures, margin initiatives and demand commentary across life sciences, food, chemicals and other industrial end markets.
Company updates also cover investor conference presentations, earnings conference calls and governance changes such as independent director appointments. Product categories associated with the business include laboratory balances, retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors and X-ray analyzers, supported by a global sales and service network.
Mettler-Toledo International Inc. (NYSE:MTD) will present at the 5th Annual Evercore ISI HealthCONx Conference on November 30, 2022, at 11:20 a.m. ET. The presentation will be available via live webcast on the company's investor relations page, with a replay accessible for seven days. Mettler-Toledo is a global leader in precision instruments, serving key industries like life sciences, food, and chemicals. The company holds strong market positions and has a robust sales and service network in over 140 countries, highlighting its commitment to innovation and financial growth.
Mettler-Toledo International (NYSE:MTD) announced the appointment of Ingrid Zhang to its Board of Directors, effective February 1, 2023. Zhang currently serves as President of China, Innovative Medicines at Novartis and has held various leadership roles in multinational pharmaceutical companies. Wah-Hui Chu will retire from the Board in May 2023 due to reaching the mandatory retirement age. Chair Robert F. Spoerry emphasized Zhang's extensive experience in the pharmaceutical industry and strategic insights for the dynamic Chinese market, while thanking Chu for his 16 years of service to the company.
Mettler-Toledo International reported a 4% increase in sales for Q3 2022, totaling $985.8 million. In local currency, sales grew 10%, with net earnings per share (EPS) rising to $9.76. Adjusted EPS reached $10.18, a 17% year-over-year increase. Regional performance varied: 11% growth in the Americas, 12% decline in Europe, and 7% growth in Asia. The company announced a new $2.5 billion share repurchase authorization while projecting 10% local currency sales growth and adjusted EPS of $38.95 to $39.05 for 2022.
Mettler-Toledo International announces an investor meeting in Boston on November 7, 2022. The event will feature a live webcast starting at 8:30 a.m. Eastern Time, accessible via www.mt.com/investors. A replay will be available for seven days post-event. Mettler-Toledo is a leading global supplier of precision instruments, holding top market positions in various sectors, including life sciences and manufacturing, with products sold in over 140 countries.
Mettler-Toledo International (NYSE:MTD) will hold a conference call on November 3, 2022, at 5:00 p.m. ET to discuss its quarterly results. Investors can access the live webcast at www.mt.com/investors, with a replay available until November 10, 2022. Mettler-Toledo is a leading global supplier of precision instruments, holding number-one market positions in various sectors. Their innovative solutions serve critical roles in R&D, quality control, and manufacturing across industries like life sciences, food, and chemicals. The company's extensive sales and service network spans over 140 countries.
Mettler-Toledo International Inc. (NYSE: MTD) has appointed Roland Diggelmann to its Board of Directors. Diggelmann previously served as CEO of Smith & Nephew Plc and Roche Diagnostics, bringing over 10 years of experience in the pharma/life sciences industry. His extensive international expertise and leadership in multinational companies are expected to provide valuable insights for Mettler-Toledo. The company is recognized as a leader in precision instruments across various industries, with a strong sales and service network worldwide.
Mettler-Toledo International Inc. (NYSE: MTD) reported a strong second quarter for 2022 with sales increasing by 6% year-over-year to $978.4 million. In local currency, sales grew 10%, driven by robust performance in the Americas (11% growth) and a 14% increase in Asia/Rest of World. Net earnings per diluted share rose to $9.29 from $7.85 in the prior year, with adjusted EPS up 16% to $9.39. Looking ahead, the company anticipates local currency sales growth of 9% to 10% for the year, with adjusted EPS guidance of $38.85 to $39.05.
Mettler-Toledo International Inc. (NYSE:MTD) will host a conference call on July 29, 2022, at 7:00 a.m. Eastern Time to discuss its quarterly results. Investors can access the live webcast at www.mt.com/investors, with a replay available until August 5, 2022.
Recognized as a leader in precision instruments and services, Mettler-Toledo holds significant market positions across various sectors, including life sciences, food, and chemicals. The company operates in over 140 countries and boasts a strong financial track record driven by innovation and strategic execution.
Mettler-Toledo International reported a 12% increase in sales for Q1 2022, totaling $897.8 million. Adjusted EPS rose 20% to $7.87, up from $6.56 year-over-year. Growth was driven by strong demand across its Laboratory and Industrial segments, particularly in the Americas, which saw a 16% increase. However, management warned of macro uncertainties including supply chain challenges and inflation. Looking forward, Mettler anticipates 8% local currency sales growth in 2022 and adjusted EPS between $38.20 to $38.50.
Mettler-Toledo International (NYSE: MTD) announced its participation in the BofA Securities 2022 Healthcare Conference on May 11, 2022, at 10:40am PT. The live webcast can be accessed via the investor relations section of their website, with a replay available for seven days. Mettler-Toledo is recognized as a global leader in precision instruments and services, holding strong market positions across various industries like life sciences and food. The company emphasizes its extensive sales network and proven growth strategies that contribute to its strong financial performance.